Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Grupos
Abstract
The absence of nigrosome 1 on brain MRI and the hyperechogenicity of substantia nigra (SNh) by transcranial sonography are two useful biomarkers in the diagnosis of parkinsonisms. We aimed to evaluate the absence of nigrosome 1 in amyotrophic lateral sclerosis (ALS) and to address its meaning.
© 2021. The Author(s).
Datos de la publicación
- ISSN/ISSNe:
- 0340-5354, 1432-1459
- Tipo:
- Article
- Páginas:
- 1631-1640
- PubMed:
- 34379200
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,359 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF NEUROLOGY SPRINGER HEIDELBERG
Citas Recibidas en Web of Science: 6
Documentos
- No hay documentos
Filiaciones
Keywords
- Amyotrophic lateral sclerosis, Hyperechogenicity of substantia nigra, Nigrosome 1, Primary lateral sclerosis, Progressive muscular atrophy, Ultrasound
Campos de Estudio
Cita
ISABEL MORENO M,TEMBL J,MAZÓN M,JOSE CANADA A,MARTÍ L,SEVILLA T,VÁZQUEZ JF. Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis. J. Neurol. 2021. 269. (3):p. 1631-1640. IF:6,682. (1).
Portal de investigación